CPCB-RPE1 / Regenerative Patch Technologies - LARVOL DELTA

PATCH-AMD: A Phase IIb Randomized, Multicenter Trial of Subretinal CPCB-RPE1 in Advanced Dry AMD (Geographic Atrophy) (clinicaltrials.gov) - P2 | N=24 | Recruiting | Sponsor: Regenerative Patch Technologies, LLC | Not yet recruiting ➔ Recruiting

Enrollment open • Age-related Macular Degeneration • Dry Age-related Macular Degeneration • Macular Degeneration • Ophthalmology • Retinal Disorders

PATCH-AMD: A PHASE IIB, RANDOMIZED, ASSESSOR-MASKED, MULTICENTER CLINICAL TRIAL TO ASSESS THE SAFETY AND EFFICACY OF SUBRETINAL IMPLANTATION OF THE CPCB-RPE1 IMPLANT IN SUBJECTS WITH ADVANCED, DRY AMD (GEOGRAPHIC ATROPHY) (clinicaltrials.gov) - P2 | N=24 | Not yet recruiting | Sponsor: Regenerative Patch Technologies, LLC

Metastases • New P2 trial • Age-related Macular Degeneration • Dry Age-related Macular Degeneration • Macular Degeneration • Ophthalmology • Retinal Disorders